August 25, 2025

DexCom, Inc. (DXCM) Stock Analysis: Unpacking the 24% Potential Upside for Investors

DexCom, Inc. (NASDAQ: DXCM) is a standout player in the healthcare sector, specializing in medical devices that transform diabetes management and metabolic health monitoring. With a market capitalization of $32.26..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a 21.60% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a towering figure in the biotechnology sector, with a market capitalization of $62.48 billion. The company’s innovative approach to healthcare solutions has not..

DaVita Inc. (DVA) Stock Analysis: Navigating Growth in Healthcare with a 9.36% Potential Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services, a critical component of chronic kidney failure management. With a market capitalization of..

IQVIA Holdings (IQV) Stock Analysis: Analyst Consensus Signals 12.5% Upside Potential

Investors eyeing the healthcare sector may find IQVIA Holdings, Inc. (NYSE: IQV) an intriguing opportunity. With its current position in the diagnostics and research industry, IQVIA is leveraging its extensive..

Cencora, Inc. (COR) Stock Report: Analyzing a Potential 13.90% Upside in the Healthcare Sector

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically in medical distribution. With a substantial market capitalization of $56.73 billion, Cencora..

Bristol-Myers Squibb (BMY) Stock Analysis: A Look at Its 5.18% Dividend Yield and Growth Prospects

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor attention with its robust dividend yield and strategic positioning in the biopharmaceutical industry. With a..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 90% Revenue Growth Amidst Valuation Challenges

For investors eyeing the healthcare technology sector, Tempus AI, Inc. (TEM) presents a compelling, albeit complex, investment opportunity. With a current market capitalization of $13.99 billion, Tempus AI has carved..

Walgreens Boots Alliance, Inc. (WBA)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a noteworthy player in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic animal health products. With..

Centene Corporation (CNC) Stock Analysis: Navigating a 18.58% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC), a key player in the healthcare plans industry, operates as a healthcare enterprise serving under-insured and uninsured families alongside commercial organizations in the United States. With..

Waters Corporation (WAT) Investor Outlook: Analyzing a 15.90% Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT), a leader in the Healthcare sector’s Diagnostics & Research industry, presents an intriguing opportunity for investors as it navigates the complexities of the global market. Headquartered..

Molina Healthcare Inc (MOH) Stock Analysis: Potential Upside and Strategic Positioning in the Healthcare Plans Sector

Molina Healthcare Inc (NYSE: MOH), a stalwart in the healthcare plans sector, continues to capture investor attention with its strategic positioning and growth potential. With a market capitalization of $9.45..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking 66% Upside Potential Amidst Strong Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a pioneering force in the biotechnology sector, continues to capture the attention of investors with its strong market positioning and robust growth prospects. With a..

Koninklijke Philips N.V. (PHG) Stock Analysis: A Healthcare Giant with a 15.62% Upside Potential

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, stands out as a compelling investment opportunity. With a market capitalization of $26.94 billion, this Dutch multinational is..

Bio-Techne Corp (TECH) Stock Analysis: Promising 14.39% Upside Amidst Strong Analyst Support

Bio-Techne Corporation (NASDAQ: TECH), a leader in the biotechnology sector, is garnering significant attention from investors thanks to its robust market position and promising growth potential. With a market capitalization..

Roivant Sciences Ltd. (ROIV): Analyst Consensus Signals a Promising 43.55% Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company headquartered in London, is capturing investor attention with a compelling potential upside of 43.55%. Despite facing challenges in revenue growth and..

Charles River Laboratories (CRL) Investor Outlook: Navigating Growth with a 6.32% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a compelling player in the healthcare sector, specifically within the diagnostics and research industry. Based in Wilmington, Massachusetts, Charles River has..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential 17.64% Upside and Robust Revenue Growth Attract Investors

Universal Health Services, Inc. (NYSE: UHS), a key player in the healthcare sector, has been making waves with its strong financial metrics and promising growth potential. With a market capitalization..

Chemed Corp (CHE) Stock Analysis: Healthcare Leader Offers 23.57% Potential Upside

Chemed Corp (NYSE: CHE) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $6.69 billion, Chemed operates..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 29.84% Potential Upside in the Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND), headquartered in Hellerup, Denmark, continues to captivate investors in the healthcare sector with its promising pipeline and robust revenue growth. Specializing in biopharmaceutical innovations, Ascendis..

Search

Funds

August 25, 2025

Search

Funds

August 25, 2025

FTSE 100

Funds